Business
Grant of Options, Exercise of Options & PDMR
Microlise Group plc has announced the issuance of 37,527 new ordinary shares following the exercise of options by directors and a former employee, with the total issued share capital increasing to 115,983,483 ordinary shares. Additionally, 1,394,062 options were granted to employees and directors under the 2026 Performance Share Plan, vesting in December 2028 and subject to relative TSR, EPS growth, and ESG performance criteria. These transactions, involving the exercise and grant of options at £0.001 per share, are expected to be admitted to trading on AIM on July 2, 2026. Disclaimer*
About this update from Microlise Group Plc
26 June 2026 Microlise Group plc ("Microlise", "the Group" or "the Company") Grant of Options, Exercise of Options, Director/PDMR Dealing and Total Voting Rights Exercise of Options under the 2023 Microlise Performance Share Plan Microlise Group plc (AIM: SAAS), a leading provider of SaaS based transport technology solutions to fleet operators, announces that it has issued and allotted 37,527 new ordinary shares of 0.001 pence each ("Ordinary Shares") following the exercise of share options by a former employee and certain directors, including persons discharging managerial responsibilities ("PDMRs") as set out below. PDMR Role Number of Options exercised Total Shareholding Nadeem Raza1 Chief Executive Officer 13,712 13,712 Nick Wightman Chief Financial Officer 6,014 145,367 Stephen Watson Director of Product 4,330 70,843 Trevor McGahan Chief Operating Officer 4,811 115,666 Jackie Mitchell Director of Human Resources 3,913 82,016 Total 32,780 427,604 1. Nadeem Raza retains the voting rights in 58,032,442 ordinary shares, held by The Raza Hamilton Trust (the "Trust"), but not the beneficial interest. The above shares are subject to a two-year holding period in accordance with the terms of the 2023 Microlise Performance Share Plan. Application has been made to the London Stock Exchange for the 37,527 new Ordinary Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will become effective and trading will commence at 8.00 a.m. on 2 July 2026. The Company advises that, following Admission, the Company's issued share capital will be 115,983,483 Ordinary Shares. The Company does not hold any Ordinary Shares in treasury. As such the Company's total number of Ordinary Shares with voting rights is 115,983,483. The above figure of 115,983,483 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules. 2026 Grant of Options In addition, the Company announces that on 25 June 2026 it granted 1,394,062 options over Ordinary Shares to certain employees and directors, including persons discharging managerial responsibilities ("PDMRs"), under the 2026 Microlise Performance Share Plan ("2026 PSP Options"). The 2026 PSP Options will ...
View stock analysis, news, and events for Microlise Group Plc